Patent · US Active

Hydantoin derivatives as metalloproteinase inhibitors

US7655664B2 · kind B2 · utility

3Cited by

35References

9Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Balint Gabos · Lund, SE
Michael Lundkvist · Lund, SE
Magnus Munck Af Rosenschold · Lund, SE
Igor Shamovsky · Mölndal, SE
Pavol Zlatoidsky · Mölndal, SE

Key dates

Filing date	Dec 14, 2005
Grant date	Feb 2, 2010
Priority date	—
Expiry date	Aug 8, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I): wherein R1, R2, A, A1 and B are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.